MEDIVET DAP: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIVET DAP
Largest movements
- Receivables within one year +€584,067
up €584,067 (+138%), from €424,393 to €1.0m
of which Other amounts receivable: +€928,101
- Cash -€37,336
down €37,336 (-64.8%), from €57,627 to €20,290
mainly Receivables within one year (-€584,067) and Trade debts (-€2,013)
- Stocks and contracts -€23,143
down €23,143 (-100%), from €23,143 to €0
- Profit (loss) carried forward +€388,197
up €388,197 (+82.7%), from €469,157 to €857,354
- Tax, wage and social debts +€132,839
up €132,839 (+1,430%), from €9,290 to €142,129
of which Taxes: +€136,585
- Gross operating margin +€434,382
up €434,382 (+420%), from €103,545 to €537,927
- Taxes +€123,432
up €123,432 (+660%), from €18,697 to €142,129
- Staff costs -€13,622
down €13,622 (-100%), from €13,622 to €0
- Write-downs +€12,325
up €12,325 (+292%), from €4,218 to €16,543
- Financial income +€10,759
up €10,759 (+1,956,216%), from €1 to €10,760
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €511,357 | €1,028,751 | +€517,393 | +101% |
| Fixed assets | 21/28 | €4,924 | €0 | -€4,924 | -100% |
| Tangible fixed assets | 22/27 | €4,924 | €0 | -€4,924 | -100% |
| Furniture and vehicles | 24 | €4,924 | €0 | -€4,924 | -100% |
| Current assets | 29/58 | €506,434 | €1,028,751 | +€522,317 | +103% |
| Stocks and contracts in progress | 3 | €23,143 | €0 | -€23,143 | -100% |
| Stocks | 30/36 | €23,143 | €0 | -€23,143 | -100% |
| Amounts receivable within one year | 40/41 | €424,393 | €1,008,460 | +€584,067 | +138% |
| Trade receivables | 40 | €402,537 | €58,503 | -€344,034 | -85.5% |
| Other amounts receivable | 41 | €21,856 | €949,957 | +€928,101 | +4,246% |
| Cash at bank and in hand | 54/58 | €57,627 | €20,290 | -€37,336 | -64.8% |
| Deferred charges and accrued income | 490/1 | €1,271 | €0 | -€1,271 | -100% |
| Total equity and liabilities | 10/49 | €511,357 | €1,028,751 | +€517,393 | +101% |
| Equity | 10/15 | €489,617 | €877,814 | +€388,197 | +79.3% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €469,157 | €857,354 | +€388,197 | +82.7% |
| Amounts payable | 17/49 | €21,741 | €150,937 | +€129,196 | +594% |
| Amounts payable within one year | 42/48 | €20,111 | €150,937 | +€130,826 | +651% |
| Trade debts | 44 | €10,820 | €8,808 | -€2,013 | -18.6% |
| Suppliers | 440/4 | €10,820 | €8,808 | -€2,013 | -18.6% |
| Taxes, remuneration and social security | 45 | €9,290 | €142,129 | +€132,839 | +1,430% |
| Taxes | 450/3 | €5,544 | €142,129 | +€136,585 | +2,464% |
| Remuneration and social security | 454/9 | €3,746 | €0 | -€3,746 | -100% |
| Accrued charges and deferred income | 492/3 | €1,630 | €0 | -€1,630 | -100% |
| Non-recurring operating income | 76A | €7,250 | €513,576 | +€506,326 | +6,984% |
| Remuneration, social security and pensions | 62 | €13,622 | €0 | -€13,622 | -100% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,686 | €0 | -€3,686 | -100% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €4,218 | €16,543 | +€12,325 | +292% |
| Other operating charges | 640/8 | €604 | €1,228 | +€624 | +103% |
| Non-recurring operating charges | 66A | €1,386 | €0 | -€1,386 | -100% |
| Gross operating margin | 9900 | €103,545 | €537,927 | +€434,382 | +420% |
| Operating profit (loss) | 9901 | €80,029 | €520,156 | +€440,127 | +550% |
| Financial income | 75/76B | €1 | €10,760 | +€10,759 | +1,956,216% |
| Recurring financial income | 75 | €1 | €10,760 | +€10,759 | +1,956,216% |
| Financial charges | 65/66B | €3,085 | €589 | -€2,496 | -80.9% |
| Recurring financial charges | 65 | €3,085 | €589 | -€2,496 | -80.9% |
| Profit (loss) for the period before taxes | 9903 | €76,945 | €530,326 | +€453,382 | +589% |
| Income taxes | 67/77 | €18,697 | €142,129 | +€123,432 | +660% |
| Profit (loss) for the period | 9904 | €58,248 | €388,197 | +€329,950 | +566% |
| Profit (loss) for the period to be appropriated | 9905 | €58,248 | €388,197 | +€329,950 | +566% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.